Bi-and tri-specific antibodies in non-Hodgkin Lymphoma: current data and perspectives

The challenges in developing bispecific antibodies for non-Hodgkin lymphomaПодробнее

Bispecific antibodies for non-Hodgkin lymphomaПодробнее

Tri-specific Antibody SAR442257 in RRMM and Non- Hodgkin Lymphoma | Fredrik Schjesvold | #ASH24Подробнее

Bispecific antibodies in NHL: current insights and ongoing studiesПодробнее

Bispecific Antibody Treatment in Non-Hodgkin Lymphoma: Epcoritamab - Blood Cancers OncTalk 2023Подробнее

Treating Lymphoma with Bispecific Antibodies | LRF WebinarsПодробнее

Evolving Role of Bispecific Antibodies in B-cell Non-Hodgkin Lymphomas (B-NHL)Подробнее

Current immunotherapeutic approaches in DLBCL: the value of CAR-T cells and bispecific antibodiesПодробнее

Immunotherapy Treatments B-Cell Non-Hodgkin's: Bispecific Antibodies - Blood Cancer Video LibraryПодробнее

Blood Cancer Video Library - Brody - Bi-specific Antibody - DLBCL & Follicular LymphomaПодробнее

Evolving Role of Bispecific Antibodies in B-cell Non-Hodgkin Lymphomas (B-NHL)Подробнее

Clinical guidance for the use of bispecific antibodies in NHLПодробнее

Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma...Подробнее

Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew MatasarПодробнее

Emerging Immunotherapy Treatments for B-Cell Non-Hodgkin's Lymphoma: Bispecific AntibodiesПодробнее

What are trispecific antibodies? #myelomaПодробнее

CAR-T vs bispecific antibodies for lymphomaПодробнее

Evolving Role of Bispecific Antibodies in B-cell Non-Hodgkin Lymphomas (B-NHL)Подробнее

Bispecific Antibodies in LymphomaПодробнее